Richard H Kim MD

Cardiology•Delray Beach, FL

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Physician

Join to View Full Profile

5210 Linton BlvdSuite 101Delray Beach, FL 33484
Phone+1 561-495-7230
Fax+1 561-495-5618

Education & Training

University of Miami/Jackson Health SystemFellowship, Cardiovascular Disease, 1993 - 1996
Temple University HospitalResidency, Internal Medicine, 1990 - 1993
Lewis Katz School of Medicine at Temple UniversityClass of 1990

Certifications & Licensure

FL State Medical License 1997 - 2027
PA State Medical License 1992 - 1998

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer Start of enrollment: 2011 Apr 07
Completed
Phase 2
Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer Start of enrollment: 2011 Jun 01
Completed
Phase 1
SOM 230 and Gemcitabine in Advanced Pancreatic Cancer Start of enrollment: 2011 Jun 01
Completed
Phase 1
Phase I Trial of Combination of FOLFIRI and SOM 230 Start of enrollment: 2011 Sep 01
Completed
Phase 1
SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
COMPLETED
PHASE2
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer Start of enrollment: 2013 Apr 01
Terminated
Phase 2
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
RECRUITING
PHASE3
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Start of enrollment: 2014 Feb 01
Completed
Phase 2
Single Agent Regorafenib in Refractory Advanced Biliary Cancers Start of enrollment: 2014 Jun 05
Completed
Phase 2
Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer Start of enrollment: 2014 May 22
Completed
Phase 1
BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer Start of enrollment: 2014 Oct 30
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

3 citations
Treatment of Gastric and Gastroesophageal Cancers—Do We Really Need Anthracyclines?
Noman Ashraf, Richard B. Kim
JAMA Oncology. 2017-09-01
186 citations
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors
Albiruni Ryan Abdul Razak, Morten Mau-Soerensen, Nashat Y. Gabrail, John F. Gerecitano, Anthony F. Shields
Journal of Clinical Oncology. 2016-10-31
11 citations
Use of Radiation Therapy in Locally Advanced Pancreatic Cancer Improves Survival: A SEER Database Analysis.
Monique Sajjad, Sachin Batra, Sarah E. Hoffe, Richard B. Kim, Gregory M. Springett
American Journal of Clinical Oncology. 2016-01-19

Professional Memberships

American College of Cardiology - ACC
Member